FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4286716089> ?p ?o ?g. }

• W4286716089 endingPage "1493" @default.
• W4286716089 startingPage "1484" @default.
• W4286716089 abstract "Mucoepidermoid carcinoma (MEC) and adenosquamous carcinoma (ASC) have overlapping histopathological appearances and sites of occurrence, which may cause diagnostic difficulty impacting subsequent treatment. We conducted a systematic review of the scientific literature to determine whether molecular alterations were sufficiently different in MEC and ASC to aid in classifying the two entities. We searched Medline, Embase and Web of Science for studies reporting molecular determinations of ASC and/or MEC and screened retrieved records for eligibility. Two independent researchers reviewed included studies, assessed methodological quality and extracted data. Of 8623 identified records, 128 articles were included for analysis: 5 which compared the two tumors in the same investigation using the same methods and 123 which examined the tumors separately. All articles, except one were case series of moderate to poor methodological quality. The 5 publications examining both tumors showed that 52/88 (59%) MEC and 0% of 110 ASC had rearrangement of the MAML2 gene as detected by FISH and/or RT-PCR, but did not investigate other genes. In the entire series MEC had MAML2 gene rearrangement in 1337/2009 (66.6%) of tumors studied. The articles examining tumors separately found that MEC had mutations in EGFR (11/329 cases, 3.3%), KRAS (11/266, 4.1%) and ERBB2 (9/126, 7.1%) compared with ASC that had mutations in EGFR (660/1705, 38.7%), KRAS (143/625, 22.9%) and ERBB2 (6/196, 3.1%). The highest level of recurrent mutations was in pancreatic ASC where (108/126, 85.7%) reported mutations in KRAS. The EGFR mutations in ASC were similar in number and kind to those in lung adenocarcinoma. By standards of systematic review methodology and despite the large number of retrieved studies, we did not find adequate evidence for a distinctive molecular profile of either MEC or ASC that could definitively aid in its classification, especially in histologically difficult cases that are negative for MAML2 rearrangement. The case series included in this review indicate the relevance of MAML2 rearrangement to support the diagnosis of MEC, findings that should be confirmed by additional research with adequate study design." @default.
• W4286716089 created "2022-07-23" @default.
• W4286716089 creator A5002901793 @default.
• W4286716089 creator A5014188852 @default.
• W4286716089 creator A5018513504 @default.
• W4286716089 creator A5029075663 @default.
• W4286716089 creator A5067299042 @default.
• W4286716089 creator A5080656632 @default.
• W4286716089 creator A5091750589 @default.
• W4286716089 date "2022-10-01" @default.
• W4286716089 modified "2023-10-03" @default.
• W4286716089 title "Mucoepidermoid carcinoma (MEC) and adenosquamous carcinoma (ASC), the same or different entities?" @default.
• W4286716089 cites W1550826633 @default.
• W4286716089 cites W1964172790 @default.
• W4286716089 cites W1965523766 @default.
• W4286716089 cites W1967220865 @default.
• W4286716089 cites W1971542014 @default.
• W4286716089 cites W1973990301 @default.
• W4286716089 cites W1980541833 @default.
• W4286716089 cites W1993717883 @default.
• W4286716089 cites W1994395943 @default.
• W4286716089 cites W2004133899 @default.
• W4286716089 cites W2011498834 @default.
• W4286716089 cites W2023041077 @default.
• W4286716089 cites W2037195118 @default.
• W4286716089 cites W2043687095 @default.
• W4286716089 cites W2052962319 @default.
• W4286716089 cites W2073277724 @default.
• W4286716089 cites W2075236896 @default.
• W4286716089 cites W2076277208 @default.
• W4286716089 cites W2081606773 @default.
• W4286716089 cites W2089947672 @default.
• W4286716089 cites W2096295569 @default.
• W4286716089 cites W2108100098 @default.
• W4286716089 cites W2110415813 @default.
• W4286716089 cites W2117004442 @default.
• W4286716089 cites W2130234665 @default.
• W4286716089 cites W2161374186 @default.
• W4286716089 cites W2212574864 @default.
• W4286716089 cites W2402421755 @default.
• W4286716089 cites W2464731156 @default.
• W4286716089 cites W2469091285 @default.
• W4286716089 cites W2475260156 @default.
• W4286716089 cites W2752589022 @default.
• W4286716089 cites W2793350103 @default.
• W4286716089 cites W2888153006 @default.
• W4286716089 cites W2945783178 @default.
• W4286716089 cites W2989536171 @default.
• W4286716089 cites W2999783791 @default.
• W4286716089 cites W3011576436 @default.
• W4286716089 cites W3045897752 @default.
• W4286716089 cites W3046769031 @default.
• W4286716089 cites W3081040615 @default.
• W4286716089 cites W3118615836 @default.
• W4286716089 cites W91108901 @default.
• W4286716089 doi "https://doi.org/10.1038/s41379-022-01100-z" @default.
• W4286716089 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35871081" @default.
• W4286716089 hasPublicationYear "2022" @default.
• W4286716089 type Work @default.
• W4286716089 citedByCount "3" @default.
• W4286716089 countsByYear W42867160892022 @default.
• W4286716089 countsByYear W42867160892023 @default.
• W4286716089 crossrefType "journal-article" @default.
• W4286716089 hasAuthorship W4286716089A5002901793 @default.
• W4286716089 hasAuthorship W4286716089A5014188852 @default.
• W4286716089 hasAuthorship W4286716089A5018513504 @default.
• W4286716089 hasAuthorship W4286716089A5029075663 @default.
• W4286716089 hasAuthorship W4286716089A5067299042 @default.
• W4286716089 hasAuthorship W4286716089A5080656632 @default.
• W4286716089 hasAuthorship W4286716089A5091750589 @default.
• W4286716089 hasBestOaLocation W42867160892 @default.
• W4286716089 hasConcept C121608353 @default.
• W4286716089 hasConcept C126322002 @default.
• W4286716089 hasConcept C142724271 @default.
• W4286716089 hasConcept C143998085 @default.
• W4286716089 hasConcept C2776512503 @default.
• W4286716089 hasConcept C2776835612 @default.
• W4286716089 hasConcept C2777546739 @default.
• W4286716089 hasConcept C2780859518 @default.
• W4286716089 hasConcept C2781182431 @default.
• W4286716089 hasConcept C2781187634 @default.
• W4286716089 hasConcept C526805850 @default.
• W4286716089 hasConcept C71924100 @default.
• W4286716089 hasConceptScore W4286716089C121608353 @default.
• W4286716089 hasConceptScore W4286716089C126322002 @default.
• W4286716089 hasConceptScore W4286716089C142724271 @default.
• W4286716089 hasConceptScore W4286716089C143998085 @default.
• W4286716089 hasConceptScore W4286716089C2776512503 @default.
• W4286716089 hasConceptScore W4286716089C2776835612 @default.
• W4286716089 hasConceptScore W4286716089C2777546739 @default.
• W4286716089 hasConceptScore W4286716089C2780859518 @default.
• W4286716089 hasConceptScore W4286716089C2781182431 @default.
• W4286716089 hasConceptScore W4286716089C2781187634 @default.
• W4286716089 hasConceptScore W4286716089C526805850 @default.
• W4286716089 hasConceptScore W4286716089C71924100 @default.
• W4286716089 hasFunder F4320337351 @default.
• W4286716089 hasIssue "10" @default.
• W4286716089 hasLocation W42867160891 @default.

• next